OTTAWA, Jan. 6, 2016 /PRNewswire/ - Autonomous_ID, an innovator in personal wearable platforms, said today the U.S. Patent and Trade Office (USPTO) has issued patents for two inventions central to the company's products and services.
USPTO issued patent 9,188,963 on November 17, 2015 for a gait-based authentication system used to determine if a user of a device is an authenticated user of restricted resources.
The patent protects the technology at the heart of the company's workforce and personal identity systems based on the Bio_Sole. These systems enable users to authenticate identity with a minimal risk of error while protecting their privacy. The Bio_Sole neither stores nor transmits biometric information.
On December 8, 2015 USPTO issued patent 9,204,797 for a gait-based biometric device capable of determining changes in a user's medical condition. The company's Bio_Sole, together with its Pedo_Biometric software, enable signature comparisons over time that can be used to provide early detection of a range of ailments such as diabetes, Parkinson's, Alzheimer's, dementia and other pathological conditions.
According to Todd D. Gray, the chairman and CEO of autonomous_ID, "These patents enable autonomous_ID to provide its clients with secure, unobtrusive, wearable devices that deliver benefits, either in better physical security for restricted resources, and in better systems to detect changes in users' health conditions."
Headquartered in Ottawa, Canada, autonomous_ID is a provider of a new category of personalized wearable platforms with application across market segments of identity security, mobile health and general performance and fitness. Its AiDA analytics research cloud will lead to new insights and discoveries into human movement and mobility.